Perstorp and Corbion Jointly Launch Breakthrough Innovation for Adhesives

Perstorp and Corbion jointly announce a breakthrough innovation for adhesives. Resulting from a partnership agreement both companies signed in 2011, a new lactide caprolactone copolymer has been developed that delivers major benefits in hot melt adhesive applications.

The product is part of Perstorp’s Capa™ Lactide and the two companies are market leaders in their respective fields of caprolactones (Perstorp) and lactides (Corbion). The new material is expected to be the first in a series of innovations for the adhesive industry.

The new product has a renewable content exceeding 80% and is fully compostable – providing adhesives manufacturers with a new technology to improve food safety aspects of packaging and at the same time meet the growing demand for more sustainable products. Equally importantly, the new material delivers no compromise on performance and allows formulators to remain competitive.

Corbion’s Senior Vice President Biochemicals, Marco Bootz, said: “This new material represents the culmination of two years’ joint development work with Perstorp. It will create a strong technology platform for the development of polymers that provide a genuine alternative to traditional materials like EVA (ethylene vinyl acetate) and mPE (metallocene-catalyzed polyethylene) for the adhesive industry.”

“Through this partnership we provide adhesives manufacturers with a competitive advantage through safe innovative materials that deliver high performance with a reduced environmental footprint,” said Håkan Björnberg, Vice President Innovation at Perstorp. “We expect this innovation to be the first of many.”

The new Capa™ product is expected to be commercially available in the final quarter of this year and will be brought to market by Corbion.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.